Rousselot, a leader in collagen and gelatin innovation, has launched Nextida, a groundbreaking platform of collagen peptide compositions designed to target specific health benefits. Backed by rigorous scientific research, Nextida aims to transform natural health and wellness products through a deep understanding of collagen’s properties. Nextida’s library of collagen peptide compositions has been meticulously validated through preclinical and clinical trials. This research ensures the efficacy and safety of these peptides, offering targeted health benefits beyond traditional formulations. The first commercialized product, Nextida.GC, aims to reduce post-meal sugar spikes naturally, with promising results to be unveiled at the SupplySide West event.
Gaëtan Noiret, Rousselot’s global director of health and nutrition, emphasizes that Nextida represents a new era of innovation, unlocking health benefits previously unknown for collagen peptides, particularly in preventative health. The platform supports the development of high-quality nutraceutical ingredients tailored to modern consumer trends, heralding a significant advancement in natural health solutions.
Home » Nextida: Pioneering a New Frontier in Collagen Peptide Innovation
Nextida: Pioneering a New Frontier in Collagen Peptide Innovation
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Nucleotide-Rich Meals and Uric Acid
September 29, 2026
Cumin Seed Extract and Its Wound-Healing Potential
September 29, 2026
Beetroot Juice and Heart Health After Menopause
September 21, 2026
Puerarin and the Gut–Liver–Brain Axis in Depression
September 21, 2026
Object Recognition Test (ORT): A Versatile Tool for Memory Research in Mice
September 14, 2026
Yeast Protein on Gut Barrier Function and Inflammation
September 14, 2026